Rx to OTC Switches
The International HealthCare staff has domestic and international experience in ten successful switches, including:
- Gyne-Lotrimin®
- Mycelex®
- Nicorette®
- Imodium-AD®
- H2-antagonists (Pepcid-AC®, Zantac-75®, and Axid-AR®)
- PPI’s (Prilosec®, Prevacid® and Zegerid®)
We work with our clients to identify new products ideal for the OTC market while providing these clients with a full understanding of the steps required achieve FDA and EMEA approval.
Need more information? Review our white papers on